A combined immune prognostic index in esophageal squamous cell carcinoma patients treated with anti-PD-1 therapy.
Shoujian JiChuanhua ZhaoRongrui LiuYan WangQing YangHua YangJian-Ming XuPublished in: Therapeutic advances in medical oncology (2023)
The CIPI score was a robust biomarker for prognostic prediction in ESCC patients treated with anti-PD-1 therapy and was immunotherapy specific. The CIPI score may also be applicable for prognostic prediction in pan-cancers.
Keyphrases